These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

237 related items for PubMed ID: 32072336

  • 1. Microbiota changes associated with ADNP deficiencies: rapid indicators for NAP (CP201) treatment of the ADNP syndrome and beyond.
    Kapitansky O, Giladi E, Jaljuli I, Bereswill S, Heimesaat MM, Gozes I.
    J Neural Transm (Vienna); 2020 Feb; 127(2):251-263. PubMed ID: 32072336
    [Abstract] [Full Text] [Related]

  • 2. Activity-dependent neuroprotective protein deficiency models synaptic and developmental phenotypes of autism-like syndrome.
    Hacohen-Kleiman G, Sragovich S, Karmon G, Gao AYL, Grigg I, Pasmanik-Chor M, Le A, Korenková V, McKinney RA, Gozes I.
    J Clin Invest; 2018 Nov 01; 128(11):4956-4969. PubMed ID: 30106381
    [Abstract] [Full Text] [Related]

  • 3. The autism/neuroprotection-linked ADNP/NAP regulate the excitatory glutamatergic synapse.
    Sragovich S, Malishkevich A, Piontkewitz Y, Giladi E, Touloumi O, Lagoudaki R, Grigoriadis N, Gozes I.
    Transl Psychiatry; 2019 Jan 15; 9(1):2. PubMed ID: 30664622
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. The ADNP Syndrome and CP201 (NAP) Potential and Hope.
    Gozes I.
    Front Neurol; 2020 Jan 15; 11():608444. PubMed ID: 33329371
    [Abstract] [Full Text] [Related]

  • 8. A novel davunetide (NAPVSIPQQ to NAPVSIPQE) point mutation in activity-dependent neuroprotective protein (ADNP) causes a mild developmental syndrome.
    Gozes I, Shazman S.
    Eur J Neurosci; 2023 Jul 15; 58(2):2641-2652. PubMed ID: 36669790
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. New horizons in schizophrenia treatment: autophagy protection is coupled with behavioral improvements in a mouse model of schizophrenia.
    Merenlender-Wagner A, Shemer Z, Touloumi O, Lagoudaki R, Giladi E, Andrieux A, Grigoriadis NC, Gozes I.
    Autophagy; 2014 Jul 15; 10(12):2324-32. PubMed ID: 25484074
    [Abstract] [Full Text] [Related]

  • 11. Tauopathy in the young autistic brain: novel biomarker and therapeutic target.
    Grigg I, Ivashko-Pachima Y, Hait TA, Korenková V, Touloumi O, Lagoudaki R, Van Dijck A, Marusic Z, Anicic M, Vukovic J, Kooy RF, Grigoriadis N, Gozes I.
    Transl Psychiatry; 2020 Jul 13; 10(1):228. PubMed ID: 32661233
    [Abstract] [Full Text] [Related]

  • 12. Activity-dependent neuroprotective protein snippet NAP reduces tau hyperphosphorylation and enhances learning in a novel transgenic mouse model.
    Vulih-Shultzman I, Pinhasov A, Mandel S, Grigoriadis N, Touloumi O, Pittel Z, Gozes I.
    J Pharmacol Exp Ther; 2007 Nov 13; 323(2):438-49. PubMed ID: 17720885
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Protection against tauopathy by the drug candidates NAP (davunetide) and D-SAL: biochemical, cellular and behavioral aspects.
    Shiryaev N, Pikman R, Giladi E, Gozes I.
    Curr Pharm Des; 2011 Nov 13; 17(25):2603-12. PubMed ID: 21728979
    [Abstract] [Full Text] [Related]

  • 15. The autism-mutated ADNP plays a key role in stress response.
    Sragovich S, Ziv Y, Vaisvaser S, Shomron N, Hendler T, Gozes I.
    Transl Psychiatry; 2019 Sep 18; 9(1):235. PubMed ID: 31534115
    [Abstract] [Full Text] [Related]

  • 16. Activity-dependent neuroprotective protein (ADNP) exhibits striking sexual dichotomy impacting on autistic and Alzheimer's pathologies.
    Malishkevich A, Amram N, Hacohen-Kleiman G, Magen I, Giladi E, Gozes I.
    Transl Psychiatry; 2015 Feb 03; 5(2):e501. PubMed ID: 25646590
    [Abstract] [Full Text] [Related]

  • 17. NAP (davunetide) enhances cognitive behavior in the STOP heterozygous mouse--a microtubule-deficient model of schizophrenia.
    Merenlender-Wagner A, Pikman R, Giladi E, Andrieux A, Gozes I.
    Peptides; 2010 Jul 03; 31(7):1368-73. PubMed ID: 20417241
    [Abstract] [Full Text] [Related]

  • 18. Sexual divergence in microtubule function: the novel intranasal microtubule targeting SKIP normalizes axonal transport and enhances memory.
    Amram N, Hacohen-Kleiman G, Sragovich S, Malishkevich A, Katz J, Touloumi O, Lagoudaki R, Grigoriadis NC, Giladi E, Yeheskel A, Pasmanik-Chor M, Jouroukhin Y, Gozes I.
    Mol Psychiatry; 2016 Oct 03; 21(10):1467-76. PubMed ID: 26782054
    [Abstract] [Full Text] [Related]

  • 19. Sexual divergence in activity-dependent neuroprotective protein impacting autism, schizophrenia, and Alzheimer's disease.
    Gozes I.
    J Neurosci Res; 2017 Jan 02; 95(1-2):652-660. PubMed ID: 27870441
    [Abstract] [Full Text] [Related]

  • 20. Sex-Specific ADNP/NAP (Davunetide) Regulation of Cocaine-Induced Plasticity.
    Toren Y, Ziv Y, Sragovich S, McKinney RA, Barak S, Shazman S, Gozes I.
    J Mol Neurosci; 2024 Sep 10; 74(3):76. PubMed ID: 39251453
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.